April 24, 2017
The Ministry of Health, Labor and Welfare (MHLW) on April 21 announced the second batch of drugs granted its sakigake fast-track designation , including Biogen’s Alzheimer’s hopeful aducanumab and Ono Pharmaceutical’s Opdivo (nivolumab) as a biliary tract cancer treatment. The...read more